GM-CSF, Human：Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) was initially characterized as a growth factor that can support the in vitro colony formation of granulocyte-macrophage progenit

產品型號：Z02695

更新時間：2025-11-06

廠商性質：代理商

訪問量：197

服務熱線

0592-5771844

立即咨詢

產品分類

PRODUCT CLASSIFICATION

重組蛋白

查看全部產品

flag抗體A01868如何進行鑒定，有哪些方法

eBlot L1快速濕轉儀的測量結果如何進行數據處理和分析

依科賽胎牛血清干貨來啦！記得收藏！

掌握8道移液器內體積誤差的調整技巧

單道移液器操作技巧與維護保養

產品介紹

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) was initially characterized as a growth factor that can support the in vitro colony formation of granulocyte-macrophage progenitors. Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) is produced by a number of different cell types, including activated T cells, B cells, macrophages, mast cells, endothelial cells, and fibroblasts, in response to cytokine of immune and inflammatory stimuli. Besides granulocyte-macrophage progenitors, Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) is a growth factor for erythroid, megakaryocyte, and eosinophil progenitors. On mature hematopoietic, monocytes/macrophages and eosinophils. Human Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) can induce human endothelial cells to migrate and proliferate. Additionally, Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) can stimulate the proliferation of a number of tumor cell lines, including osteogenic sarcoma, carcinoma, and adenocarcinoma cell lines.

產品簡介

Species

Human

Protein Construction

Expressed with an N-terminal Met.

GM-CSF (Ala18-Glu144)
Accession # P04141

Purity

> 95% as analyzed by SDS-PAGE

Endotoxin Level

< 1 EU/μg of protein by gel clotting method

Biological Activity

ED50 < 0.5 ng/ml, measured by proliferation assay of TF-1 cells, corresponding to a specific activity of > 2.0 × 106 U/mg

Expression System

E. coli

Apparent Molecular Weight

~14 kDa, on SDS-PAGE under reducing conditions.

Formulation

Lyophilized after extensive dialysis against 10 mM PB, pH 7.0.

Reconstitution

It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH?O up to 100 μg/ml.

Storage & Stability

Upon receiving, this product remains stable for 6 months at lower than -70°C. Upon reconstitution, the product should be stable for 1 week at 4°C or for 3 months at -20°C. For long term storage it is recommended that a carrier protein (example 0.1% BSA) be added. Avoid repeated freeze-thaw cycles.

上一個：Z02988IL-1β, Mouse(CHO-expressed)